Devi Nandana Suchitra Devi
Postdoctoral Research Associate in Translational Biology
Dr. Devi Nandana is a Postdoctoral Research Scientist in the Thakurta lab at the Oxford Translational Myeloma Centre (OTMC), within the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford.
Her research focuses on understanding the biological drivers of molecularly defined high-risk multiple myeloma and investigating the role of epigenetic therapies as a potential treatment strategy. She is particularly interested in the mechanisms underlying drug response and resistance, and in exploring how epigenetic reprogramming might help reverse resistance and improve therapeutic outcomes.
Devi completed her PhD at Newcastle University, UK, where she studied the impact of TET2 mutations in acute myeloid leukaemia (AML) and the role of epigenetic drugs such as azacytidine as a treatment approach for TET2-mutated AML. She then worked as a Postdoctoral Research Assistant at the Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, where she continued to explore the role of mannose metabolism in haematopoiesis and AML using both in vitro and in vivo models.
She obtained her integrated Bachelor of Science–Master of Science (BS-MS) dual degree in Biological Sciences with a minor in Chemistry from the Indian Institute of Science Education and Research (IISER), Bhopal, India, after being awarded the Innovation in Science Pursuit for Inspired Research (INSPIRE) Fellowship from the Department of Science and Technology, Government of India.
Devi has broad expertise in assay development, cell-based drug-screening, genome editing, flow cytometry, mouse models, molecular biology techniques, RNA sequencing and methylation profiling data analysis. Her work bridges basic and translational research, contributing to the development of precision medicine strategies in haematological malignancies.
In addition to her research, Devi is actively involved in science communication and public engagement, participating in outreach initiatives aimed at raising awareness of cancer research and inspiring future scientists.